Disease Gene Patenting: The Clinician's Dilemma
One strategy for defenders of gene patenting is to adopt a constructivist interpretation of genetic testing to avoid the “product of nature doctrine.” I argue that accepting this view (which seems to be the approach of the U.S. Office of Patents and Trademarks) results in an intolerable dilemma for...
| Main Author: | |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Cambridge Univ. Press
1998
|
| In: |
Cambridge quarterly of healthcare ethics
Year: 1998, Volume: 7, Issue: 4, Pages: 433-435 |
| Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |